Taken together, these findings suggest that the induction of lung and lymph node metastasis, lymphangiogenesis, and tumor growth by highly metastatic lung cancer cells is mediated by enhanced expression of COX2, VEGFR-3-driven signaling, and angiopoietin. Here, PTGS2 is linked to lung cancer.